LFMD vs STLN
LifeMD, Inc. - Common Stock · Starling Oncology, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | LFMD | STLN |
|---|---|---|
| Price | $2.20 | $3.50 |
| Market Cap | $106.09M | $356.97M |
| P/E | 7.39 | — |
| P/B | — | — |
| P/S | 0.55 | 0.71 |
| ROE | — | — |
| Net Margin | 7.4% | -12.1% |
| Gross Margin | 85.7% | — |
| Revenue Growth | 25.3% | 27.8% |
| Dividend Yield | — | — |
| EPS | $0.30 | -$0.59 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.